Advertisement

Index by author

October 01, 2017; Volume 69,Issue 4

B

  1. Beyer, Eric C.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  2. Braisted, John C.

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

C

  1. Cerbai, Elisabetta

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

  2. Coussens, Nathan P.

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

D

  1. Dhein, Stefan

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

F

  1. Ferdinandy, Peter

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

G

  1. Garland, Christopher J.

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

  2. Gottesman, Michael M.

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

  3. Green, Colin R.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

H

  1. Hall, Matthew D.

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

K

  1. Kwak, Brenda R.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

L

  1. Laird, Dale W.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  2. Lampe, Paul D.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  3. Levy, Finn Olav

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  4. Leybaert, Luc

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

M

  1. Mannaioni, Guido

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

  2. Masi, Alessio

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

N

  1. Naus, Christian C.

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  2. Novella Romanelli, Maria

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

O

  1. Ohlstein, Eliot H.

    1. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors
      Csaba Szabo and Andreas Papapetropoulos
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 497-564; DOI: https://doi.org/10.1124/pr.117.014050

P

  1. Papapetropoulos, Andreas

    1. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors
      Csaba Szabo and Andreas Papapetropoulos
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 497-564; DOI: https://doi.org/10.1124/pr.117.014050

  2. Peryea, Tyler

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

S

  1. Sartiani, Laura

    1. The Hyperpolarization-Activated Cyclic Nucleotide–Gated Channels: from Biophysics to Pharmacology of a Unique Family of Ion Channels
      Laura Sartiani, Guido Mannaioni, Alessio Masi, Maria Novella Romanelli and Elisabetta Cerbai
      Christopher J. Garland, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 354-395; DOI: https://doi.org/10.1124/pr.117.014035

  2. Schulz, Rainer

    1. Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications
      Luc Leybaert, Paul D. Lampe, Stefan Dhein, Brenda R. Kwak, Peter Ferdinandy, Eric C. Beyer, Dale W. Laird, Christian C. Naus, Colin R. Green and Rainer Schulz
      Finn Olav Levy, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 396-478; DOI: https://doi.org/10.1124/pr.115.012062

  3. Simeonov, Anton

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

  4. Sittampalam, G. Sitta

    1. Small-Molecule Screens: A Gateway to Cancer Therapeutic Agents with Case Studies of Food and Drug Administration–Approved Drugs
      Nathan P. Coussens, John C. Braisted, Tyler Peryea, G. Sitta Sittampalam, Anton Simeonov and Matthew D. Hall
      Michael M. Gottesman, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 479-496; DOI: https://doi.org/10.1124/pr.117.013755

  5. Szabo, Csaba

    1. International Union of Basic and Clinical Pharmacology. CII: Pharmacological Modulation of H2S Levels: H2S Donors and H2S Biosynthesis Inhibitors
      Csaba Szabo and Andreas Papapetropoulos
      Eliot H. Ohlstein, ASSOCIATE EDITOR
      Pharmacological Reviews October 2017, 69 (4) 497-564; DOI: https://doi.org/10.1124/pr.117.014050
Back to top

In this issue

Advertisement